Radiation therapy firm Varian Medical Systems has received FDA 510(k) clearance for a new proton therapy eye dose calculation module that has been incorporated into company's Eclipse radiation therapy treatment planning system.
The proton eye dose calculation module enables physicians to create plans for delivering proton radiation beam treatment for ocular cancers while protecting the critical structures in and around the human eye, according to the Palo Alto, CA-based vendor.
By AuntMinnie.com staff writers
December 7, 2005
Related Reading
BrainLab, Varian extend product agreement, November 23, 2005
Guertin tapped as Varian CEO, November 18, 2005
Varian debuts Aria, DART, October 17, 2005
Varian, Xoft sign distribution deal, October 13, 2005
Varian gets New Zealand install, board appointments, August 30, 2005
Copyright © 2005 AuntMinnie.com
